The addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most?

Overview of attention for article published in SpringerPlus, May 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

"The addition of bevacizumab to standard chemotherapy in breast cancer..." New to our #BreastCancer collection http://t.co/Itomdc…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.